Hybrid Virtual Group Model for Substance Use Disorder Therapy: A Scoping Review
Substance Abuse and Rehabilitation · 2025-05 · Volume 16 · 137-146
DOI: 10.2147/sar.s518266 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Substance Abuse and Rehabilitation, 2025-05. Verfasst von Edward A Trimble und 5 weiteren Autor:innen. Beteiligte Einrichtung: Mayo Clinic Alix School of Medicine, Rochester, MN, USA. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 23 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).
Themen: Sucht und Abhängigkeit
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Mayo Clinic Alix School of Medicine, Rochester, MN, USA.
- Department of Psychiatry and Psychology, Mayo Clinic, Rochester, MN, USA.
- Mayo Clinic Libraries, Mayo Clinic, Rochester, MN, USA.
- Department of Psychiatry, University of Iowa, Iowa City, IA, USA.
- Department of Biostatistics, University of Iowa, Iowa City, IA, USA.
ORCID-Profile: Edward A Trimble, Nicholas L Bormann, Alyssa H Kalata, Dana Gerberi, Tyler S Oesterle
Zitieren
APA
Trimble, E. A., Bormann, N. L., Kalata, A. H., Gerberi, D., Arndt, S., & Oesterle, T. S. (2025). Hybrid Virtual Group Model for Substance Use Disorder Therapy: A Scoping Review. Substance Abuse and Rehabilitation, Volume 16, 137-146. https://doi.org/10.2147/sar.s518266
Vancouver
Trimble EA, Bormann NL, Kalata AH, Gerberi D, Arndt S, Oesterle TS. Hybrid Virtual Group Model for Substance Use Disorder Therapy: A Scoping Review. Substance Abuse and Rehabilitation. 2025;Volume 16:137-146. doi:10.2147/sar.s518266
BibTeX
@article{Trimble2025,
author = {Trimble, Edward A and Bormann, Nicholas L and Kalata, Alyssa H and Gerberi, Dana and Arndt, Stephan and Oesterle, Tyler S},
title = {Hybrid Virtual Group Model for Substance Use Disorder Therapy: A Scoping Review},
journal = {Substance Abuse and Rehabilitation},
year = {2025},
volume = {Volume 16},
pages = {137--146},
doi = {10.2147/sar.s518266}
}
EUVIMED